These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8780820)

  • 1. Use of immunological markers and continuous-time Markov models to estimate progression of HIV infection in homosexual men.
    Hendriks JC; Satten GA; Longini IM; van Druten HA; Schellekens PT; Coutinho RA; van Griensven GJ
    AIDS; 1996 Jun; 10(6):649-56. PubMed ID: 8780820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model.
    Hendriks JC; Craib KJ; Veugelers PJ; van Druten HA; Coutinho RA; Schechter MT; van Griensven GJ
    Int J Epidemiol; 2000 Jun; 29(3):565-72. PubMed ID: 10869332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
    Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
    Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis.
    Hendriks JC; Satten GA; van Ameijden EJ; van Druten HA; Coutinho RA; van Griensven GJ
    AIDS; 1998 Aug; 12(12):1537-44. PubMed ID: 9727576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low T-cell responses to CD3 plus CD28 monoclonal antibodies are predictive of development of AIDS.
    Roos MT; Prins M; Koot M; de Wolf F; Bakker M; Coutinho RA; Miedema F; Schellekens PT
    AIDS; 1998 Oct; 12(14):1745-51. PubMed ID: 9792374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of smoothing techniques for CD4 data in a Markov model with states defined by CD4: an example on the estimation of the HIV incubation time distribution.
    Sypsa V; Touloumi G; Kenward M; Karafoulidou A; Hatzakis A
    Stat Med; 2001 Dec; 20(24):3667-76. PubMed ID: 11782025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS.
    Maas JJ; Dukers N; Krol A; van Ameijden EJ; van Leeuwen R; Roos MT; de Wolf F; Coutinho RA; Keet IP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):254-9. PubMed ID: 9803967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low T cell reactivity to combined CD3 plus CD28 stimulation is predictive for progression to AIDS: correlation with decreased CD28 expression.
    Roos MT; Miedema F; Meinesz AP; De Leeuw NA; Pakker NG; Lange JM; Coutinho RA; Schellekens PT
    Clin Exp Immunol; 1996 Sep; 105(3):409-15. PubMed ID: 8809127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort.
    Longini IM; Clark WS; Karon JM
    Am J Epidemiol; 1993 Jun; 137(11):1229-40. PubMed ID: 8100682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200 x 10(6)/l but free of AIDS-defining clinical disease.
    Keet IP; Krol A; Koot M; Roos MT; de Wolf F; Miedema F; Coutinho RA
    AIDS; 1994 Nov; 8(11):1577-83. PubMed ID: 7848594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men.
    Spijkerman IJ; Prins M; Goudsmit J; Veugelers PJ; Coutinho RA; Miedema F; de Wolf F
    AIDS; 1997 Sep; 11(11):1383-8. PubMed ID: 9302449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HIV RNA setpoint theory revisited.
    Geskus RB; Prins M; Hubert JB; Miedema F; Berkhout B; Rouzioux C; Delfraissy JF; Meyer L
    Retrovirology; 2007 Sep; 4():65. PubMed ID: 17888148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men.
    Schellekens PT; Roos MT; De Wolf F; Lange JM; Miedema F
    J Clin Immunol; 1990 Mar; 10(2):121-7. PubMed ID: 2140115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid declines in total lymphocyte counts and hemoglobin concentration prior to AIDS among HIV-1-infected men.
    Lau B; Gange SJ; Phair JP; Riddler SA; Detels R; Margolick JB
    AIDS; 2003 Sep; 17(14):2035-44. PubMed ID: 14502006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.
    Koot M; Keet IP; Vos AH; de Goede RE; Roos MT; Coutinho RA; Miedema F; Schellekens PT; Tersmette M
    Ann Intern Med; 1993 May; 118(9):681-8. PubMed ID: 8096374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression to acquired immunodeficiency syndrome is influenced by CD4 T-lymphocyte count and time since seroconversion.
    Begtrup K; Melbye M; Biggar RJ; Goedert JJ; Knudsen K; Andersen PK
    Am J Epidemiol; 1997 Apr; 145(7):629-35. PubMed ID: 9098180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion.
    de Wolf F; Spijkerman I; Schellekens PT; Langendam M; Kuiken C; Bakker M; Roos M; Coutinho R; Miedema F; Goudsmit J
    AIDS; 1997 Dec; 11(15):1799-806. PubMed ID: 9412697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low CD4 T cell counts before HIV-1 seroconversion do not affect disease progression in Ethiopian factory workers.
    Mekonnen Y; Geskus RB; Hendriks JC; Messele T; Borghans J; Miedema F; Wolday D; Coutinho RA; Dukers NH
    J Infect Dis; 2005 Sep; 192(5):739-48. PubMed ID: 16088823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3- populations suggest regulatory responses linked to loss of CD4 lymphocytes. The Multicenter AIDS Cohort Study.
    Margolick JB; Donnenberg AD; Muñoz A; Park LP; Bauer KD; Giorgi JV; Ferbas J; Saah AJ
    J Acquir Immune Defic Syndr (1988); 1993 Feb; 6(2):153-61. PubMed ID: 8094458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.